The Komen controversy about Planned Parenthood was just the tip of the iceberg as far as I'm concerned, and I am thrilled to link to an op ed on the subject in today's Los Angeles Times by Peggy Orenstein. I won't repeat what Orenstein eloquently describes. But while she urges readers to give their breast cancer-related donations elsewhere, she does not name names, and that I will do.
Send your money to Breast Cancer Action. Its "think before you pink" campaign long predates the recent attention to Komen. What's more, they fit Orenstein's criteria of a worthy group: not shying away from objectively reviewing the science of screening; aggressively pushing for more investigation into the causes of cancer, including environmental causes; and refusing money from corporations whose policies or products are not good for women's health.